Drugs / Cervicovaginal secretions
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03769688 | Mar 2022 → Dec 2023 | bacterial vaginosis | Johns Hopkins University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cervicovaginal secretions | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03769688 ↗ |
| Modality | Other / unclassified | “using cervicovaginal secretions (CVS), a process referred to as vaginal microbiota transplant (VMT)” NCT03769688 ↗ |
| Route | Other | “single intravaginal dose” NCT03769688 ↗ |